Latest News

Grants in 2016

Congratulations to CTC research collaborators and CTC staff who have been awarded over $4 million in National Health and Medical Research Council (NHMRC) and Cancer Australia and co-funder grants.... Read More

People at very high risk of melanoma would benefit from monitoring

Australia has one of the highest rates of melanoma in the world. A newly published study has shown that for people at very high risk, specialised surveillance clinics would cut costs and improve ... Read More

Career Achievement Award for John Simes

John Simes, director of CTC, has been honoured by an accolade from his colleagues in cancer research for his achievements over broad areas of leadership, advocacy, research, and teaching-the Cance... Read More

Published Research

Antiplatelet agents and the prevention of spontaneous preterm birth: A systematic review and meta-analysis

Obstetrics and Gynecology. Online 13 Jan 2017

van Vliet EO, Askie LA, Mol BW, Oudijk MA

An evaluation of the telehealth facilitation of diabetes and cardiovascular care in remote Australian Indigenous communities: protocol for the telehealth eye and associated medical services network [TEAMSnet] project, a pre–post study design

BMC Health Services Research 2017; 17(1): 13

Brazionis L, Jenkins A, Keech A, Ryan C, Bursell SE

Fear of new or recurrent melanoma after treatment for localised melanoma

Psycho-Oncology. Online 5 Jan 2017

Bell KJ, Mehta Y, Turner RM, Morton RL, Dieng M, Saw R, Guitera P, McCaffery K, Low D, Low C, Jenkins M, Irwig L, Webster AC.

Is it all about price? Why requests for government subsidy of anticancer drugs were rejected in Australia

Internal Medicine Journal. Online 9 Dec 2016

Karikios DJ, Chim L, Martin A, Nagrial A, Howard K, Salkeld G, Stockler MR

See more publications

Upcoming Events

ANZGOG Annual Scientific Meeting: 29 March - 1 April 2017

Careers at CTC


No Vacancies

TRIAL LOGIN
TRIALS DATA SYSTEMS
TRIAL RESULTS
STUDY WITH US
MAKE A DONATION